Search

everythinglearnresearchcommunity

for

Search:↓

New compounds were found to help increase hair growth and decrease hair loss.

The developed model can predict effective 5-alpha-reductase enzyme inhibitors.

Prostaglandin D2 increases testosterone production in skin cells through a process involving reactive oxygen species, which could be a new target for treating hair loss and other skin conditions driven by testosterone.

The treatment reduced hair growth and testosterone in women with excess hair and had some effects on stress responses.

5α-Reductase inhibitors can help treat hair loss, acne, and prostate issues by reducing DHT levels.

Changing the C-ring structure in certain compounds can make them better at blocking a specific human enzyme.

Finasteride causes reproductive malformations in male rats.

Blocking a specific enzyme might help treat obesity and diabetes, but more research is needed to ensure it's safe.

Human bone cells mainly produce a type 1 enzyme that may help regulate bone health.

Triptorelin effectively treats central precocious puberty in Chinese children with minimal side effects.

Scalp hair 17-OHP and androstenedione levels can help monitor treatment in CAH patients.

MK-386 lowers DHT in blood and skin but not in semen.

Medroxyprogesterone acetate injections are more effective than topical ointment in treating excessive hair growth in women.

Certain compounds, especially those with a propionic substituent, could potentially be new treatments for hair loss and similar disorders.

Exposure to certain sex hormones can increase health risks, while some hormone therapies may offer benefits for specific conditions.

FCE 28260 is a stronger and longer-lasting inhibitor of 5α-reductase than finasteride, which may make it a better treatment for certain medical conditions.

CYP11A1 is crucial for skin health and disease by producing important steroids.

The method produces finasteride with a 92% yield.

17β-estradiol may help hair growth by increasing cannabinoid receptor type 1.

The treatment effectively reduced hair growth and was safe for patients with PCOS, but it needs better bleeding control.

Glucocorticoids and thyroid hormones together are essential for fetal fat development.

Both treatments helped hair regrowth in alopecia areata, with isopropanol being better tolerated.

Correcting vitamin D and progesterone deficiencies can significantly improve hair loss, acne, and BPH symptoms.

Certain genetic variants reduce enzyme activity, contributing to non-classic congenital adrenal hyperplasia.

Chlormadinone acetate is a strong, well-tolerated hormone used in birth control and hormone therapy with benefits for menstrual pain and skin conditions.

Affected males are born with ambiguous genitalia, raised as females, but develop male traits at puberty due to enzyme deficiency.

The treatment improved acne, seborrhoea, and hirsutism, with some side effects like spotting and nervousness.

DHEA therapy improves pubic hair growth and psychological well-being in young females with central adrenal insufficiency.

5αR inhibitors help slow early prostate cancer cell growth, suggesting combined treatments are needed.

Lack or blocking of SRD5a, a key component in hormone creation, can lead to conditions like pseudohermaphrodism and affect hair growth, bone mass, muscle strength, and reproductive health. More research is needed on its regulation from fertilization to adulthood.